LRPAP1 and pachyonychia congenita: In terms of the IRR and aHR of PC, females exhibited higher risks compared to males in the subgroups of SAP, RAP, and CP with AP, with percentages of 37.8% in RAP, 6.2% in SAP, and 3.7% in CP with AP groups (Table 5).